Behdarvandian, Paria
Nasr-Esfahani, Ali http://orcid.org/0000-0002-6278-8038
Tavalaee, Marziyeh
Pashaei, Kosar
Naderi, Nushin
Darmishonnejad, Zahra
Hallak, Jorge
Aitken, Robert J.
Gharagozloo, Parviz
Drevet, Joël R. http://orcid.org/0000-0003-3077-6558
Nasr-Esfahani, Mohammad Hossein http://orcid.org/0000-0003-1983-3435
Article History
Received: 11 May 2023
Accepted: 19 September 2023
First Online: 30 November 2023
Declarations
:
: This study was carried out at the Isfahan Fertility and Infertility Center and was approved by the Royan Institute’s ethics committee (IR.ACECR.ROYAN.REC.1401.031). All male patients who participated in the study signed a consent form.
: All authors approved the final submitted manuscript.
: Collectively, the authors do not declare any competing interests. For the sake of transparency, PG RJA and JRD are respectively CEO and scientific advisors to a US-based biotechnology company (CellOxess, Ewing, NJ, USA) that contributes to preventive medicine with a focus on the production of antioxidant dietary supplements. CellOxess did not contribute in any way to this study. JRD and MHNE are respectively Managing Editor and member of the editorial board of <i>Basic and Clinical Andrology</i>.